Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure LRCX Q1 2026 Earnings EPS Surpasses Estimates by Nearly 5 Amid Challenging Environment WHWK Q1 2026 Earnings EPS Beat Drives Stock Rally Despite No Revenue EPAC Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Higher SANA Q1 2026 Earnings Narrower Loss Per Share Surprises on Operational Progress CUK Q1 2026 Earnings EPS Misses Estimate but Stock Rallies on Operational Momentum